✦ LIBER ✦

Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer

✍ Scribed by Robert B. Livingston; Susan Schulman; Brian R. Griffin; Bill L. Tranum; Saul E. Rivkin; Ronald S. Goldberg; Carol J. Fabian; Neel Hammond; Henry Hynes

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 644 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870401)59:7<1249::aid-cncr2820590703>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy and high-dose c

Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A southwest oncology group study

✍ Georgiana K. Ellis; Stephanie Green; Susan Schulman; Bill L. Tranum; Ronald S. G 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

Systemic chemotherapy for advanced breas

Systemic chemotherapy for advanced breast cancer

✍ Alfred A. Fracchia; Joseph H. Farrow; Yehuda G. Adam; Jorge Monroy; William H. K 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Primary systemic chemotherapy for inflam

Primary systemic chemotherapy for inflammatory breast cancer

✍ Sarah Sinclair; Sandra M. Swain 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract The advent of multimodality therapy for patients with inflammatory breast cancer (IBC), consisting of neoadjuvant chemotherapy, particularly taxanes, surgery, radiotherapy, and hormonal therapy, has improved survival. A pathologic complete response to neoadjuvant chemotherapy in locally

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

✍ Stephen E. Jones; Brian G. M. Durie; Sydney E. Salmon 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Combination chemotherapy for breast canc

Combination chemotherapy for breast cancer metastatic to bone marrow

✍ Rosalba Rodriguez-Kraul; Gabriel N. Hortobagyi; Aman U. Buzdar; George R. Blumen 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Seventy-nine patients with metastatic breast cancer underwent examination of their bone marrow as part of their staging workup. Thirty-one (3%) showed no evidence of bone marrow involvement (BM-); 48 (61%) were found to have bone marrow metastases (BM+). Both groups of patients were treated with int

Treatment of poor prognosis nonseminomat

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

✍ Robert F. Ozols; Albert B. Deisseroth; Nasser Javadpour; Audrey Barlock; Gerald 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

A new intensive four drug combination chemotherapy regimen, termed PVeBV, consisting of cis-plathum, vinblastine, bleomycin, and VP-16, was administered to six previously untreated patients with poor prognosis advanced nonseminomatous testicular cancer and to four patients who had relapsed on primar